BioMelbourne Network
Progressing BioIndustry
News and Opinions
2011
November
Alchema Completes A$15M Placement, Announces Share Purchase Plan and Proposed Demerger of Alchemia Oncology
7 November 2011Highlights · Institutional Placement of 62.5 million shares to domestic and international investors at A$0.24 raising A$15 million;· Share Purchase Plan to raise up to A$5 million; and· Proposed de-merger of Alchemia’s wholly owned subsidiary Alchemia Oncology Pty Ltd to create a stand-alone company containing all of the HyACT® oncology assets including... read more…
Phosphagenics Licenses Diclofenac Gel for Indian Market
4 November 2011Melbourne drug delivery technology company, Phosphagenics Limited (ASX: POH, OTCQX: PPGNY), has licensed TPM/diclofenac, its topical non-steroidal pain formulation, to Themis Medicare Pvt Ltd of Mumbai for the Indian market. This represents Phosphagenics’ first commercial deal in India and its first licensing agreement of its diclofenac product. Under the terms of the agreem... read more…
GE to Speed Fight against Cancer, Starting with Breast Cancer
GE CEO and Chairman Jeff Immelt and several venture capital partners today announced a healthymagination open innovation Challenge to fund promising ideas to improve breast cancer diagnostics. To learn more about this initiative, visit www.healthymagination.com. Immelt also said that GE will invest $1 billion over the next five years on R&D programs to expand its suite of advanced technologies ... read more…
October
Thomson Reuters Launches New Competitive Intelligence Solution for the Pharmaceutical Industry
30 October 2011
Thomson Reuters today announced the launch of Thomson Reuters CortellisTM, the next generation solution for the life sciences industry that brings together the company’s best-in-class drug research and development data and the latest information management technology, to transform the way pharma and biotech professionals access and use data across the entire drug research ... read more…
Global pharmaceutical executive to head local Cancer drug development CRC
Pharmaceutical industry executive, Dr Warwick Tong, has been appointed CEO of Cancer Therapeutics CRC Pty Ltd (CTx).
Based in Melbourne, CTx was founded under the CRC program to ensure that novel cancer biology was combined with early drug discovery and development capabilities within Australia.
Dr Tong, who joined CTx in early October, has worked in both the major pharmaceutical and biotechn... read more…
$10m to grow Victoria’s small technologies
Minister for Technology Gordon Rich-Phillips has announced a $10 million plan to support Victorian industry to improve productivity through the use of small technologies.
Speaking at an event hosted by Melbourne’s scientific leaders and the Australian Academy of Science tonight, Mr Rich-Phillips said the plan was part of the Victorian Coalition Government’s approach to supporting technology an... read more…
Phosphagenics' Successful $24.1m Capital Raising and $3m SPP
21 October 2011, Melbourne, Australia:
Melbourne drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has raised $24.1 million via a $17.1 million placement to institutions and sophisticated investors and a $7 million placement to a Singapore-based investor. It is intended to seek a further $3 million via a share purchase plan (SPP).
"This capital raising ... read more…
New Appointment to CSIRO Board
20 October 2011. Dr Don Rusell has been appointed to the CSIRO Board. Announcing his appointment today, Innovation Minister Senator Kim Carr said Dr Russell’s deep understanding of the workings of Government would be of great value to the CSIRO Board.
"His appointment will boost links between CSIRO and Government portfolios and agencies and bolster CSIRO’s ability to meet challenges ove... read more…
Victorian Government's $55m commitment to biotechnology
Minister Rich-Phillips said the plan was part of the Victorian Coalition Government’s suite of technology strategies under Victoria’s Technology Plan for the Future, which reflects the Coalition’s new approach to supporting technology and its commitment to driving productivity growth.“The statement sets forth the Coalition Government’s direction for Victorian biotechnology and the key role of b... read more…
Victorian Government unveils $10 million mental illness research fund
The treatment of people with a mental illness will be improved through a major research fund
unveiled today by Mental Health Minister Mary Wooldridge.
Announcing details of the $10 million fund at the Royal Melbourne Hospital Academic Centre
Research Symposium 2011, Ms Wooldridge said it delivers on a Coalition election
commitment to provide a greater research focus to mental illness.
“I... read more…
